Ervebo

Ervebo is a recombinant vaccine designed to prevent Ebola virus disease. It uses a live, non-replicating vesicular stomatitis virus to trigger an immune response against the Zaire ebolavirus.

Ervebo is used for the prevention of Ebola virus disease caused by the Zaire ebolavirus. This vaccine is intended for individuals at risk of exposure to the virus, such as healthcare workers and those living in outbreak areas. The primary use of Ervebo is to provide immunity against Ebola, helping to reduce the spread of the disease.

Common effects of Ervebo may include mild to moderate reactions at the injection site, such as pain, swelling, or redness. Some individuals may experience general symptoms like headache, fatigue, or muscle pain. These effects are typically temporary and resolve on their own.

Ervebo should be administered by healthcare professionals experienced in vaccination practices. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Pregnant women and individuals with weakened immune systems should consult their doctor before vaccination.

There are no specific interactions widely reported with Ervebo. However, it is advisable to inform your healthcare provider about any medications or supplements you are taking before receiving the vaccine. This helps ensure the safety and effectiveness of the vaccination process.